ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351521 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351521; 2) Community: the network communities that were significantly associated with the response to NSC 351521; 3) Molecule: the relationships between components within communities and NSC 351521; 4) MDR: the compounds that were significantly associated with the NSC 351521.

NSC Compound Enrichment Correlation
NSC 106969 CENTAUREIDIN 0.0352383000003058 0.31773644
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0352383000003058 0.70202233
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0352383000003058 0.59762148
NSC 264880 Dihydro-5-azacytidine 0.0352383000003058 0.4022286
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0352383000003058 0.33553579
NSC 302991 Camptothecin Derivative 0.0352383000003058 0.45275963
NSC 670653 Null 0.0368378753842886 0.42616485
NSC 679528 Null 0.0368378753842886 0.070148928
NSC 683905 Null 0.0368378753842886 0.17207624
NSC 732980 9-Hydroxy-5(3-phenylpropyl)-5H-indeno[1,2-b]indol-10-one 0.0368378753842886 0.13804646
Total:89  Current:69    [First] [Prev] [Next] [Last]